Cargando…

Utility of T-Cell Interferon-γ Release Assays for Etiological Diagnosis of Classic Fever of Unknown Origin in a High Tuberculosis Endemic Area — a pilot prospective cohort

BACKGROUND: Tuberculosis (TB), especially extrapulmonary TB is still the leading cause of fever of unknown origin (FUO) in China. However, diagnosis of TB still remains a challenge. The aim of this study was to evaluate the diagnostic value of T-SPOT.TB for etiological diagnosis of classic FUO in ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiaochun, Zhang, Lifan, Zhang, Yueqiu, Zhou, Baotong, Liu, Xiaoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718655/
https://www.ncbi.nlm.nih.gov/pubmed/26784112
http://dx.doi.org/10.1371/journal.pone.0146879
_version_ 1782410834655313920
author Shi, Xiaochun
Zhang, Lifan
Zhang, Yueqiu
Zhou, Baotong
Liu, Xiaoqing
author_facet Shi, Xiaochun
Zhang, Lifan
Zhang, Yueqiu
Zhou, Baotong
Liu, Xiaoqing
author_sort Shi, Xiaochun
collection PubMed
description BACKGROUND: Tuberculosis (TB), especially extrapulmonary TB is still the leading cause of fever of unknown origin (FUO) in China. However, diagnosis of TB still remains a challenge. The aim of this study was to evaluate the diagnostic value of T-SPOT.TB for etiological diagnosis of classic FUO in adult patients in a high TB endemic area. METHODS: We prospectively enrolled patients presenting with classic FUO in a tertiary referral hospital in Beijing, China, to investigate the diagnostic sensitivity, specificity, predictive values and likelihood ratio of T-SPOT.TB. Clinical assessment and T-SPOT.TB were performed. Test results were compared with the final confirmed clinical diagnosis. RESULTS: 387 hospitalized patients (male n = 194, female n = 193; median age 46 (range 29–59) yrs) with classic FUO were prospectively enrolled into this study. These FUOs were caused by infection (n = 158, 40.8%), connective tissue disease (n = 82, 21.2%), malignancy (n = 41, 10.6%) and miscellaneous other causes (n = 31, 8.0%), and no cause was determined in 75 (19.4%) patients. 68 cases were diagnosed as active TB eventually. The sensitivity of T-SPOT.TB for the diagnosis of active TB was 70.6% (95%CI 58.9–80.1%), while specificity was 84.4% (95%CI 79.4–88.4%), positive predictive value was 55.8% (95%CI 45.3–65.8%), negative predictive value was 91.2% (95%CI 86.7–94.2%). Among these 68 active TB patients, 12 cases were culture or histology confirmed (11 cases with positive T-SPOT.TB, sensitivity was 91.7%) and 56 cases were clinically diagnosed (37 cases with positive T-SPOT.TB, sensitivity was 66.1%); 14 cases were pulmonary TB (13 cases with positive T-SPOT.TB, sensitivity was 92.9%) and 54 cases were extrapulmonary TB (35 cases with positive T-SPOT.TB, sensitivity was 64.8%). CONCLUSIONS: For patients presenting with classic FUO in this TB endemic setting, T-SPOT.TB appears valuable for excluding active TB, with a high negative predictive value.
format Online
Article
Text
id pubmed-4718655
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47186552016-01-30 Utility of T-Cell Interferon-γ Release Assays for Etiological Diagnosis of Classic Fever of Unknown Origin in a High Tuberculosis Endemic Area — a pilot prospective cohort Shi, Xiaochun Zhang, Lifan Zhang, Yueqiu Zhou, Baotong Liu, Xiaoqing PLoS One Research Article BACKGROUND: Tuberculosis (TB), especially extrapulmonary TB is still the leading cause of fever of unknown origin (FUO) in China. However, diagnosis of TB still remains a challenge. The aim of this study was to evaluate the diagnostic value of T-SPOT.TB for etiological diagnosis of classic FUO in adult patients in a high TB endemic area. METHODS: We prospectively enrolled patients presenting with classic FUO in a tertiary referral hospital in Beijing, China, to investigate the diagnostic sensitivity, specificity, predictive values and likelihood ratio of T-SPOT.TB. Clinical assessment and T-SPOT.TB were performed. Test results were compared with the final confirmed clinical diagnosis. RESULTS: 387 hospitalized patients (male n = 194, female n = 193; median age 46 (range 29–59) yrs) with classic FUO were prospectively enrolled into this study. These FUOs were caused by infection (n = 158, 40.8%), connective tissue disease (n = 82, 21.2%), malignancy (n = 41, 10.6%) and miscellaneous other causes (n = 31, 8.0%), and no cause was determined in 75 (19.4%) patients. 68 cases were diagnosed as active TB eventually. The sensitivity of T-SPOT.TB for the diagnosis of active TB was 70.6% (95%CI 58.9–80.1%), while specificity was 84.4% (95%CI 79.4–88.4%), positive predictive value was 55.8% (95%CI 45.3–65.8%), negative predictive value was 91.2% (95%CI 86.7–94.2%). Among these 68 active TB patients, 12 cases were culture or histology confirmed (11 cases with positive T-SPOT.TB, sensitivity was 91.7%) and 56 cases were clinically diagnosed (37 cases with positive T-SPOT.TB, sensitivity was 66.1%); 14 cases were pulmonary TB (13 cases with positive T-SPOT.TB, sensitivity was 92.9%) and 54 cases were extrapulmonary TB (35 cases with positive T-SPOT.TB, sensitivity was 64.8%). CONCLUSIONS: For patients presenting with classic FUO in this TB endemic setting, T-SPOT.TB appears valuable for excluding active TB, with a high negative predictive value. Public Library of Science 2016-01-19 /pmc/articles/PMC4718655/ /pubmed/26784112 http://dx.doi.org/10.1371/journal.pone.0146879 Text en © 2016 Shi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Shi, Xiaochun
Zhang, Lifan
Zhang, Yueqiu
Zhou, Baotong
Liu, Xiaoqing
Utility of T-Cell Interferon-γ Release Assays for Etiological Diagnosis of Classic Fever of Unknown Origin in a High Tuberculosis Endemic Area — a pilot prospective cohort
title Utility of T-Cell Interferon-γ Release Assays for Etiological Diagnosis of Classic Fever of Unknown Origin in a High Tuberculosis Endemic Area — a pilot prospective cohort
title_full Utility of T-Cell Interferon-γ Release Assays for Etiological Diagnosis of Classic Fever of Unknown Origin in a High Tuberculosis Endemic Area — a pilot prospective cohort
title_fullStr Utility of T-Cell Interferon-γ Release Assays for Etiological Diagnosis of Classic Fever of Unknown Origin in a High Tuberculosis Endemic Area — a pilot prospective cohort
title_full_unstemmed Utility of T-Cell Interferon-γ Release Assays for Etiological Diagnosis of Classic Fever of Unknown Origin in a High Tuberculosis Endemic Area — a pilot prospective cohort
title_short Utility of T-Cell Interferon-γ Release Assays for Etiological Diagnosis of Classic Fever of Unknown Origin in a High Tuberculosis Endemic Area — a pilot prospective cohort
title_sort utility of t-cell interferon-γ release assays for etiological diagnosis of classic fever of unknown origin in a high tuberculosis endemic area — a pilot prospective cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718655/
https://www.ncbi.nlm.nih.gov/pubmed/26784112
http://dx.doi.org/10.1371/journal.pone.0146879
work_keys_str_mv AT shixiaochun utilityoftcellinterferongreleaseassaysforetiologicaldiagnosisofclassicfeverofunknownorigininahightuberculosisendemicareaapilotprospectivecohort
AT zhanglifan utilityoftcellinterferongreleaseassaysforetiologicaldiagnosisofclassicfeverofunknownorigininahightuberculosisendemicareaapilotprospectivecohort
AT zhangyueqiu utilityoftcellinterferongreleaseassaysforetiologicaldiagnosisofclassicfeverofunknownorigininahightuberculosisendemicareaapilotprospectivecohort
AT zhoubaotong utilityoftcellinterferongreleaseassaysforetiologicaldiagnosisofclassicfeverofunknownorigininahightuberculosisendemicareaapilotprospectivecohort
AT liuxiaoqing utilityoftcellinterferongreleaseassaysforetiologicaldiagnosisofclassicfeverofunknownorigininahightuberculosisendemicareaapilotprospectivecohort